Provided by Tiger Trade Technology Pte. Ltd.

Acurx Pharmaceuticals, LLC*

1.62
-0.0200-1.22%
Volume:19.76K
Turnover:31.81K
Market Cap:4.13M
PE:-0.20
High:1.64
Open:1.64
Low:1.55
Close:1.64
52wk High:21.00
52wk Low:1.41
Shares:2.55M
Float Shares:2.42M
Volume Ratio:1.01
T/O Rate:0.82%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-8.1800
EPS(LYR):-17.4507
ROE:-291.07%
ROA:-95.64%
PB:1.13
PE(LYR):-0.09

Loading ...

Mar 17, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 17, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Mar 10, 2025

Major Issues Report

Form 8-K - Current report
Feb 27, 2025

Major Issues Report

Form 8-K - Current report
Feb 04, 2025

Correspondence

Form CORRESP - Correspondence
Jan 31, 2025

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Jan 07, 2025

Major Issues Report

Form 8-K - Current report
Nov 13, 2024

Major Issues Report

Form 8-K - Current report
Nov 13, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 09, 2024

Major Issues Report

Form 8-K - Current report
Aug 09, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jun 18, 2024

Major Issues Report

Form 8-K - Current report
May 15, 2024

Major Issues Report

Form 8-K - Current report
May 15, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 02, 2024

[Supp]Public Prospectus

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
Mar 29, 2024

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Mar 18, 2024

Major Issues Report

Form 8-K - Current report
Mar 18, 2024

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Mar 15, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Mar 15, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]